Storebrand Asset Management’s Burning Rock Biotech BNR Stock Holding History

Storebrand Asset Management’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-675	Closed	-$6.55K	–	867
2023 Q3	$6.55K	Hold	675	–	–	﹤0.01%	858
2023 Q2	$14.7K	Hold	675	–	–	﹤0.01%	848
2023 Q1	$19K	Hold	675	–	–	﹤0.01%	838
2022 Q4	$15.2K	Hold	675	–	–	﹤0.01%	851
2022 Q3	$16.1K	Hold	675	–	–	﹤0.01%	845
2022 Q2	$19.7K	Hold	675	–	–	﹤0.01%	847
2022 Q1	$62.7K	Hold	675	–	–	﹤0.01%	815
2021 Q4	$64.4K	Buy	675 +145	+27%	+$19.9K	﹤0.01%	825
2021 Q3	$94.8K	Buy	530 +418	+373%	+$92.9K	﹤0.01%	809
2021 Q2	$32.8K	Buy	+112	New	+$33.1K	﹤0.01%	825

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Storebrand Asset Management's BNR Position: Q4 2023 in Review

Storebrand Asset Management sold out of Burning Rock Biotech (BNR) in Q4 2023, closing a stake of 675 shares — an estimated $6.55K sold.

Storebrand Asset Management first reported a position in BNR in Q2 2021 and held it in 10 quarters. The position peaked at $94.8K in Q3 2021. 19 funds tracked by Wall St. Rank hold BNR as of Q4 2023.

Storebrand Asset Management reported no remaining Burning Rock Biotech position as of Q4 2023 after selling out during the quarter.
Storebrand Asset Management sold 675 Burning Rock Biotech shares in Q4 2023, an estimated $6.55K.
Storebrand Asset Management first reported a position in Burning Rock Biotech in Q2 2021 and held it in 10 quarters.
Storebrand Asset Management's Burning Rock Biotech position peaked at $94.8K in Q3 2021.
19 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2023.

Based on Storebrand Asset Management's 13F filing for Q4 2023, filed 18 Jun 2026.